Expression of Pulmonary Surfactant-Associated Protein B in Neonatal Respiratory Distress Syndrome

Open access

Summary

Background: The aim of this study was to investigate the role of pulmonary surfactant-associated protein B (SP-B) expression in the pathogenesis of neonatal respiratory distress syndrome (RDS) via detecting the protein and mRNA expression of SP-B.

Methods: A total of 60 unrelated neonates who died of RDS were chosen as the RDS group and then subgrouped into ≤32 weeks group, 32∼37 weeks group and ≥37 weeks group (n=20). Sixty neonates who died of other diseases were enrolled as controls and subdivided into 3 matched groups based on the gestational age. Western blot assay and RT-PCR were employed.

Results: In the RDS group, SP-B protein expression was reduced or deficient in 8 neonates of which 6 had no SP-B protein expression. In the control group, only 1 had reduced SP-B protein expression. The reduced or deficient SP-B protein expression in 9 neonates of both groups was noted in the ≥37 weeks group. In the RDS group, the SP-B mRNA expression was significantly lower than that in the control group. In the ≤37 weeks group, SP-B mRNA expression was comparable between the RDS group and control group. In the 32∼37 weeks group, the SP-B mRNA expression in the RDS group was significantly reduced when compared with the control group. In the ≥37 weeks group, the SP-B mRNA expression in the RDS group was dramatically lower than that in the control group.

Conclusions: Alteration of SP-B expression is present at transcriptional and translational levels. Reduction of SP-B mRNA and protein expression is involved in the pathogenesis of RDS.

1. Lyra PP, Diniz EM, Abe-Sandes K, Angelo AL, Machado TM, Cardeal M. Surfactant protein B gene polymorphism in preterm babies with respiratory distress syndrome. Braz J Med Biol Res 2011; 44(1): 66-72.

2. Nkadi PO, Merritt TA, Pillers DA. An Over view of Pulmo - nary Surfactant in the Neonate: Gene tics, Metabolism, and the Role of Surfactant in Health and Disease. Mol Genet Metab 2009; 97: 95-101.

3. Bækvad-Hansen M, Nordestgaard BG, Dahl M. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals. Eur Respir J 2011; 37: 791-9.

4. Quasney MW, Waterer GW, Dahmer MK, et al. Asso - ciation between surfactant protein B +1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 2004; 32: 1115-19.

5. Lin Z, De Mello DE, Batanian JR, et al. Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP). Clin Genet 2000: 57: 359-69.

6. Yin XJ, Luo FP, Li AH, et al. Relationship between reduced expression of surfactant protein B and neonatal respiratory distress syndrome in twenty Han ethnic group neonates in China. Chin J Pediatr 2008: 46(1): 9-12.

7. Yin XJ, Li LH, Wang Y, et al. A study on expression of surfactant protein B in neonatal respiratory distress syndrome. Chin J Neonatol 2011; 26: 336-9.

8. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12(4): 253-74.

9. Guttentag S. Posttranslational regulation of surfactant protein B expression. Semin Perinatol 2008; 32(5): 367-70.

10. Glasser SW, Senft AP, Whitsett JA, et al. Macrophage dysfunction and susceptibility to pulmonary Pseudo mo nas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 2008; 181(1): 621-8.

11. Glasser SW, Witt TL, Senft AP, et al. Surfactant protein Cdeficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2009; 297(1): L64-72.

12. Chroneos ZC, Sever-Chroneos Z, Shepherd VL. Pulmo - nary surfactant: an immunological perspective. Cell Physiol Biochem 2010; 25(1): 13-26.

13. Mary KD, Peggy O, Pallavi PP, et al. The influence of genetic variation in surfactant protein B on severe lung injury in African American children. Crit Care Med 2011; 39(5): 1138-44.

14. De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Chew DP, Bersten AD. Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation 2004; 110: 1091-6.

15. Hanvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology 2007; 91: 311-17.

16. Elsammak YM, Attia A, Suleman M. Fibroblast growth factor-23 and hypophosphatemia in chronic obstructive pulmonary disease patients. Journal of Medical Bio - chemistry 2012; 31: 12-8.

17. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000; 161: 973-81.

18. Haataja R, Marttila R, Uimari P, Lofgren J, Ramet M, Hallman M. Respiratory distress syndrome: evaluation of genetic susceptibility and protection by transmission disequilibrium test. Hum Genet 2001; 109: 351-5.

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia

Journal Information


IMPACT FACTOR 2017: 1.378
5-year IMPACT FACTOR: 0.704



CiteScore 2017: 1.05

SCImago Journal Rank (SJR) 2017: 0.307
Source Normalized Impact per Paper (SNIP) 2017: 0.532

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 136 136 22
PDF Downloads 36 36 3